MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,517 | -77.1% | 112,218 | -40.8% | 0.00% | – |
| Q2 2023 | $623,697 | -63.8% | 189,611 | -54.8% | 0.00% | -100.0% |
| Q1 2023 | $1,723,325 | +59967.1% | 419,337 | -14.4% | 0.00% | 0.0% |
| Q4 2022 | $2,869 | -99.9% | 489,783 | -0.5% | 0.00% | 0.0% |
| Q3 2022 | $3,329,000 | +245.0% | 492,488 | +135.6% | 0.00% | – |
| Q2 2022 | $965,000 | +30.1% | 209,060 | +12.4% | 0.00% | – |
| Q1 2022 | $742,000 | -38.7% | 186,040 | -4.4% | 0.00% | – |
| Q4 2021 | $1,210,000 | -31.6% | 194,516 | +3.7% | 0.00% | -100.0% |
| Q3 2021 | $1,768,000 | -26.0% | 187,516 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $2,390,000 | -17.4% | 176,004 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $2,894,000 | -40.3% | 178,843 | -1.8% | 0.00% | -50.0% |
| Q4 2020 | $4,844,000 | +33.3% | 182,048 | -6.8% | 0.00% | 0.0% |
| Q3 2020 | $3,635,000 | -22.0% | 195,231 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $4,659,000 | +297.2% | 199,107 | -1.0% | 0.00% | +100.0% |
| Q1 2020 | $1,173,000 | +103.6% | 201,136 | +100.2% | 0.00% | – |
| Q4 2019 | $576,000 | +487.8% | 100,472 | +61.3% | 0.00% | – |
| Q3 2019 | $98,000 | -27.4% | 62,291 | +86.4% | 0.00% | – |
| Q2 2019 | $135,000 | – | 33,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |